Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of LN020 dry suspension in adolescents and adults with uncomplicated acute influenza
CTR20251548Phase 2Active
- Sponsor
- Shandong Luning Pharmaceutical
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of laninamivir octanoate in influenza, sponsored by Shandong Luning Pharmaceutical. Started Jun 2025; status: active.
02
Drugs
laninamivir octanoate
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20251548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251548.